Technology Transfer Payment. As additional consideration, upon the completion of the technology transfer activities set forth in the Technology Transfer Plan in accordance with Section 6.1, Novartis shall pay to the Company the amounts set forth in Section 6.1(c).
Appears in 2 contracts
Sources: Asset Purchase and Licensing Agreement, Asset Purchase Agreement (Opexa Therapeutics, Inc.)